Benzinga - The Dow Jones closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Chembio Diagnostics
- The Trade: Chembio Diagnostics, Inc. (NASDAQ: CEMI) 10% owner Joseph Edelman acquired a total 208,800 shares an average price of $0.45. To acquire these shares, it cost around $93.65 thousand.
- What’s Happening: Biosynex recently extended tender offer for the shares of Chembio Diagnostics, Inc..
- What Chembio Diagnostics Does: Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases.
- The Trade: Brightcove Inc. (NASDAQ: BCOV) 10% owner Jonathan Brolin acquired a total of 20,000 shares at an average price of $4.11. The insider spent around $82.24 to buy those shares.
- What’s Happening: Brightcove recently introduced new integrations with Shopify, Instagram and Salesforce Sales Cloud to its video cloud platform.
- What Brightcove Does: Brightcove Inc is a provider of cloud-based services for the video ecosystem. The firm targets its solutions at media companies, broadcasters, publishers, and corporations.
Barnwell Industries
- The Trade: Barnwell Industries, Inc. (NYSE: BRN) 10% owner Ned L Sherwood Revocable Trust acquired a total of 79,119 shares at an average price of $2.68. To acquire these shares, it cost around $212.2 thousand.
- What’s Happening: Barnwell Industries reported a rise in Q1 sales results.
- What Barnwell Industries Does: Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Don’t forget to check out our premarket coverage here
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.